We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PKG:NYSEPackaging Corporation of America Analysis

Data as of 2026-09-12 - not real-time

$234.40

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Packaging Corporation of America trades at $234.40, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have lost 5.7%. Relative strength is 43.4 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $225.33 and resistance around $256.70.
On valuation the read is fair — an earnings multiple of 30.5, absent a reliable peer benchmark. The average analyst target implies 11.1% above today's level. Revenue is growing at 14.7% on a 7.3% profit margin. The 2.58% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 22.5%, a beta of 0.73 and a maximum drawdown of 17.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

Packaging Corporation of America NYSE:PKG will be announcing earnings results this Wednesday afternoon.Packaging Corporation of America NYSE:PKG met Wall Street’s revenue expectations in Q2 CY2026, with sales up 14.Packaging Corporation of America PKG is back in focus after reporting second quarter 2026 results that topped its own...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 223.93
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 223.93
  • Analyst targets imply +11.1% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +11.1% versus the current price
  • Revenue growth of +14.7%
  • P/E ratio of 30.5

Key Metrics & Analysis

Financial Health

Revenue Growth14.70%
Profit Margin7.26%
P/E Ratio30.5
ROE14.89%
ROA8.28%
Debt/Equity94.47
P/B Ratio4.5
Op. Cash Flow$1.6B
Free Cash Flow$433.0M

Technical Analysis

TrendBullish
RSI43.4
Support$225.33
Resistance$256.70
MA 20$241.73
MA 50$241.71
MA 200$223.93
MACDBearish
VolumeIncreasing
Fear & Greed Index93.14

Valuation

Fair Value$67.46
Target Price$260.50
Upside/Downside11.13%
GradeFair
TypeGrowth
Dividend Yield2.58%

Risk Assessment

Beta0.73
Volatility22.46%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.